GSK2618960
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK2618960, covering 2017-05-09 to 2018-03-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) [Phase 2]